2022-03-04
Published Date
Healthcare
Industry
109
Pages
Peptide Vaccine global industry size is estimated to be worth US$XX million in 2022 and is forecast to a readjusted size of US$XX million by 2028 with a CAGR of XX% during the forecast period 2022-2028. Fully considering the economic change by this health crisis (Covid), Solution Phase Synthesis(SPS) accounting for XX% of the Peptide Vaccine global market in 2021, is projected to value US$XX million by 2028, growing at a revised XX% CAGR from 2023 to 2028. While Prostate Cancer segment is altered to an XX% CAGR throughout this forecast period.
The global key companies of Peptide Vaccine include Anergis, Antigen Express, Apitope Technology, Artificial Cell Technologies, Benovus Bio, Celgene Corporation, Immatics biotechnologies, Merck, ImmunoCellular Therapeutics, ISA Pharmaceuticals, Lytix Biopharma, Spotlight Innovation, OncoTherapy Science, Peptech, Pharmasyntez, Sumitomo Dainippon Pharma, TapImmune, Targovax, etc. In 2022, the global top five players have a share approximately XX% in terms of revenue.
In terms of Production Side,
This report researches the Peptide Vaccine capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of Sales Side,
This report focuses on the sales of Peptide Vaccine by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
This research report explores the key market segments: Type and Application. The report offers an in-depth breakdown of type and application segments, and their sub-segments. The growth potential of each segment have been examined by industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments, based on sales, price, and revenue for the period 2017-2028. Additionally, the report features a value chain and raw material analysis of the key segments.
Segment by Type
Solution Phase Synthesis(SPS)
Solid Phase Peptide Synthesis(SPPS)
Segment by Application
Prostate Cancer
Breast Cancer
Gastric Cancer
Lung Cancer
Pancreatic Cancer
Others
The report includes a section on key growth opportunities, which will help the key players to simplify complex issues and frame future strategies to compete in this competitive environment. This section will assist the players to boldly position their business.
Competitive Outlook
This section of the report provides an in-depth analysis of the competitive landscape of the market. The report profiles the key players in the market. It also provides reliable sales and revenue data of the players for the period 2017-2022. With the help of this report, key players, stakeholders, and other participants will be able to stay up-to-date with the recent and upcoming developments in the market, further aiding them in making efficient choices. The prime players profiled in this report are:
Companies
Anergis
Antigen Express
Apitope Technology
Artificial Cell Technologies
Benovus Bio
Celgene Corporation
Immatics biotechnologies
Merck
ImmunoCellular Therapeutics
ISA Pharmaceuticals
Lytix Biopharma
Spotlight Innovation
OncoTherapy Science
Peptech
Pharmasyntez
Sumitomo Dainippon Pharma
TapImmune
Targovax
Note: We can also add companies which are not part of the above list
Global Peptide Vaccine market: regional analysis, the major regions covered in the report are:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Q: Who are the key players in the Peptide Vaccine market
A: The key players in the market are Anergis, Antigen Express, Apitope Technology, Artificial Cell Technologies, Benovus Bio, Celgene Corporation, Immatics biotechnologies, Merck, ImmunoCellular Therapeutics, ISA Pharmaceuticals, Lytix Biopharma, Spotlight Innovation, OncoTherapy Science, Peptech, Pharmasyntez, Sumitomo Dainippon Pharma, TapImmune, Targovax.
Q: What is the revenue and sales data of the key players of Peptide Vaccine industry
A: The revenue and sales data of the key players of Peptide Vaccine industry is mentioned in full report.
Q: What are the recent and upcoming developments in the Peptide Vaccine market
A: The recent and upcoming developments in the Peptide Vaccine market are mentioned in this report.
Q: What are the main objectives of the Peptide Vaccine industry report
A: The main objectives of Peptide Vaccine industry report are to provide reliable sales and revenue data of the key players and to provide a comprehensive analysis of the competitive landscape.
Q: What are the key highlights of the Peptide Vaccine market research report
A: The key highlights of Peptide Vaccine industry report are to help players in decision making, the revenue and sales data of other players, and the recent and upcoming developments in the market.
Q: What is the scope of the Peptide Vaccine report
A: The Peptide Vaccine market report covers the market for the period 2017-2028.
Q: What is the methodology of the Peptide Vaccine report
A: The methodology of Peptide Vaccine industry report is based on primary and secondary sources.
Table of Contents
Part 1 Market Overview
1.1 Market Definition
1.2 Market Development
1.2.1 Current Situation
1.2.2 Aspects of COVID-19 Impact
1.3 By Type
Table Type of Peptide Vaccine
Figure Global Peptide Vaccine Market Share by Type in 2021
1.4 By Application
Table Application of Peptide Vaccine
Figure Global Peptide Vaccine Market Share by Application in 2021
1.5 By Region
Figure Global Peptide Vaccine Market Share by Region in 2021
Figure Asia Peptide Vaccine Market Share by Region in 2021
Part 2 Key Companies
2.1 Anergis
2.1.1 Company Profile
Table Anergis Overview List
2.1.2 Products & Services Overview
2.1.3 Sales Data List
Table Peptide Vaccine Business Operation of Anergis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
2.2 Antigen Express
2.3 Apitope Technology
2.4 Artificial Cell Technologies
2.5 Benovus Bio
2.6 Celgene Corporation
2.7 Immatics biotechnologies
2.8 Merck
2.9 ImmunoCellular Therapeutics
2.10 ISA Pharmaceuticals
2.11 Lytix Biopharma
2.12 Spotlight Innovation
2.13 OncoTherapy Science
2.14 Peptech
2.15 Pharmasyntez
2.16 Sumitomo Dainippon Pharma
2.17 TapImmune
2.18 Targovax
Part 3 Global Market Status and Future Forecast
3.1 Global Market by Region
Table Global Peptide Vaccine Market by Region, 2017-2021 (Million USD)
Figure Global Peptide Vaccine Market Share by Region in 2021 (Million USD)
Table Global Peptide Vaccine Market by Region, 2017-2021 (Volume)
Figure Global Peptide Vaccine Market Share by Region in 2021 (Volume)
Table Price List by Region, 2017-2021
3.2 Global Market by Company
Table Global Peptide Vaccine Market by Company, 2017-2021 (Million USD)
Figure Global Peptide Vaccine Market Share by Company in 2021 (Million USD)
Table Global Peptide Vaccine Market by Company, 2017-2021 (Volume)
Figure Global Peptide Vaccine Market Share by Company in 2021 (Volume)
Table Price List by Company, 2017-2021
3.3 Global Market by Type
Table Global Peptide Vaccine Market by Type, 2017-2021 (Million USD)
Figure Global Peptide Vaccine Market Share by Type in 2021 (Million USD)
Table Global Peptide Vaccine Market by Type, 2017-2021 (Volume)
Figure Global Peptide Vaccine Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
3.4 Global Market by Application
Table Global Peptide Vaccine Market by Application, 2017-2021 (Million USD)
Figure Global Peptide Vaccine Market Share by Application in 2021 (Million USD)
Table Global Peptide Vaccine Market by Application, 2017-2021 (Volume)
Figure Global Peptide Vaccine Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
3.5 Global Market by Forecast
Figure Global Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Global Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
Part 4 Asia-Pacific Market Status and Future Forecast
4.1 Asia-Pacific Market by Type
Table Asia-Pacific Peptide Vaccine Market by Type, 2017-2021 (Million USD)
Figure Asia-Pacific Peptide Vaccine Market Share by Type in 2021 (Million USD)
Table Asia-Pacific Peptide Vaccine Market by Type, 2017-2021 (Volume)
Figure Asia-Pacific Peptide Vaccine Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
4.2 Asia-Pacific Market by Application
Table Asia-Pacific Peptide Vaccine Market by Application, 2017-2021 (Million USD)
Figure Asia-Pacific Peptide Vaccine Market Share by Application in 2021 (Million USD)
Table Asia-Pacific Peptide Vaccine Market by Application, 2017-2021 (Volume)
Figure Asia-Pacific Peptide Vaccine Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
4.3 Asia-Pacific Market by Geography
4.3.1 China Market Status and Future Forecast
Figure China Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure China Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure China Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure China Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
4.3.2 Southeast Asia Market Status and Future Forecast
Figure Southeast Asia Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Southeast Asia Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Southeast Asia Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Southeast Asia Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
4.3.3 India Market Status and Future Forecast
Figure India Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure India Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure India Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure India Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
4.3.4 Japan Market Status and Future Forecast
Figure Japan Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Japan Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Japan Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Japan Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
4.3.5 Korea Market Status and Future Forecast
Figure Korea Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Korea Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Korea Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Korea Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
4.3.6 Oceania Market Status and Future Forecast
Figure Oceania Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Oceania Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Oceania Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Oceania Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
4.4 Asia-Pacific Market by Forecast
Figure Asia-Pacific Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Asia-Pacific Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
Part 5 Europe Market Status and Future Forecast
5.1 Europe Market by Type
Table Europe Peptide Vaccine Market by Type, 2017-2021 (Million USD)
Figure Europe Peptide Vaccine Market Share by Type in 2021 (Million USD)
Table Europe Peptide Vaccine Market by Type, 2017-2021 (Volume)
Figure Europe Peptide Vaccine Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
5.2 Europe Market by Application
Table Europe Peptide Vaccine Market by Application, 2017-2021 (Million USD)
Figure Europe Peptide Vaccine Market Share by Application in 2021 (Million USD)
Table Europe Peptide Vaccine Market by Application, 2017-2021 (Volume)
Figure Europe Peptide Vaccine Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
5.3 Europe Market by Geography
5.3.1 Germany Market Status and Future Forecast
Figure Germany Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Germany Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Germany Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Germany Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
5.3.2 UK Market Status and Future Forecast
Figure UK Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure UK Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure UK Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure UK Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
5.3.3 France Market Status and Future Forecast
Figure France Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure France Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure France Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure France Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
5.3.4 Italy Market Status and Future Forecast
Figure Italy Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Italy Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Italy Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Italy Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
5.3.5 Russia Market Status and Future Forecast
Figure Russia Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Russia Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Russia Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Russia Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
5.3.6 Spain Market Status and Future Forecast
Figure Spain Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Spain Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Spain Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Spain Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
5.3.6 Netherlands Market Status and Future Forecast
Figure Netherlands Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Netherlands Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Netherlands Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Netherlands Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
5.3.7 Turkey Market Status and Future Forecast
Figure Turkey Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Turkey Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Turkey Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Turkey Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
5.3.6 Switzerland Market Status and Future Forecast
Figure Switzerland Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Switzerland Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Switzerland Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Switzerland Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
5.4 Europe Market by Forecast
Figure Europe Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Europe Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
Part 6 North America Market Status and Future Forecast
6.1 North America Market by Type
Table North America Peptide Vaccine Market by Type, 2017-2021 (Million USD)
Figure North America Peptide Vaccine Market Share by Type in 2021 (Million USD)
Table North America Peptide Vaccine Market by Type, 2017-2021 (Volume)
Figure North America Peptide Vaccine Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
6.2 North America Market by Application
Table North America Peptide Vaccine Market by Application, 2017-2021 (Million USD)
Figure North America Peptide Vaccine Market Share by Application in 2021 (Million USD)
Table North America Peptide Vaccine Market by Application, 2017-2021 (Volume)
Figure North America Peptide Vaccine Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
6.3 North America Market by Geography
6.3.1 United States Market Status and Future Forecast
Figure United States Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure United States Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure United States Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure United States Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
6.3.2 Canada Market Status and Future Forecast
Figure Canada Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Canada Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Canada Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Canada Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
6.3.3 Mexico Market Status and Future Forecast
Figure Mexico Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Mexico Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Mexico Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Mexico Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
6.4 North America Market by Forecast
Figure North America Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure North America Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
Part 7 South America Market Status and Future Forecast
7.1 South America Market by Type
Table South America Peptide Vaccine Market by Type, 2017-2021 (Million USD)
Figure South America Peptide Vaccine Market Share by Type in 2021 (Million USD)
Table South America Peptide Vaccine Market by Type, 2017-2021 (Volume)
Figure South America Peptide Vaccine Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
7.2 South America Market by Application
Table South America Peptide Vaccine Market by Application, 2017-2021 (Million USD)
Figure South America Peptide Vaccine Market Share by Application in 2021 (Million USD)
Table South America Peptide Vaccine Market by Application, 2017-2021 (Volume)
Figure South America Peptide Vaccine Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
7.3 South America Market by Geography
7.3.1 Brazil Market Status and Future Forecast
Figure Brazil Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Brazil Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Brazil Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Brazil Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
7.3.2 Argentina Market Status and Future Forecast
Figure Argentina Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Argentina Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Argentina Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Argentina Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
7.3.3 Columbia Market Status and Future Forecast
Figure Columbia Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Columbia Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Columbia Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Columbia Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
7.3.4 Chile Market Status and Future Forecast
Figure Chile Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Chile Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Chile Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Chile Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
7.3.5 Peru Market Status and Future Forecast
Figure Peru Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure Peru Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure Peru Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Peru Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
7.4 South America Market by Forecast
Figure South America Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure South America Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
Part 8 Middle East & Africa Market Status and Future Forecast
8.1 Middle East & Africa Market by Type
Table Middle East & Africa Peptide Vaccine Market by Type, 2017-2021 (Million USD)
Figure Middle East & Africa Peptide Vaccine Market Share by Type in 2021 (Million USD)
Table Middle East & Africa Peptide Vaccine Market by Type, 2017-2021 (Volume)
Figure Middle East & Africa Peptide Vaccine Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
8.2 Middle East & Africa Market by Application
Table Middle East & Africa Peptide Vaccine Market by Application, 2017-2021 (Million USD)
Figure Middle East & Africa Peptide Vaccine Market Share by Application in 2021 (Million USD)
Table Middle East & Africa Peptide Vaccine Market by Application, 2017-2021 (Volume)
Figure Middle East & Africa Peptide Vaccine Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
8.3 Middle East & Africa Market by Geography
8.3.1 GCC Market Status and Future Forecast
Figure GCC Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure GCC Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure GCC Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure GCC Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
8.3.2 North Africa Market Status and Future Forecast
Figure North Africa Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure North Africa Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure North Africa Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure North Africa Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
8.3.3 South Africa Market Status and Future Forecast
Figure South Africa Peptide Vaccine Market Market Status, 2017-2021 (Million USD)
Figure South Africa Peptide Vaccine Market Market Status, 2017-2021 (Volume)
Figure South Africa Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure South Africa Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
8.4 Middle East & Africa Market by Forecast
Figure Middle East & Africa Peptide Vaccine Market Forecast, 2022E-2028F (Million USD)
Figure Middle East & Africa Peptide Vaccine Market Forecast, 2022E-2028F (Volume)
Part 9 Market Features
9.1 Product Features
9.2 Price Features
9.3 Channel Features
9.4 Purchasing Features
Part 10 Investment Opportunity
10.1 Regional Investment Opportunity
10.2 Industry Investment Opportunity
PART 11 Coronavirus Impact
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
Part 12 Conclusion
List of Tables and Figures